Alain Cohen‐solal
#165,799
Most Influential Person Now
Alain Cohen‐solal's AcademicInfluence.com Rankings
Alain Cohen‐solalmedical Degrees
Medical
#3410
World Rank
#3878
Historical Rank
Cardiology
#360
World Rank
#371
Historical Rank
Download Badge
Medical
Alain Cohen‐solal's Degrees
- PhD Cardiology Université Paris Cité
- Doctorate Medicine Université Paris Cité
Why Is Alain Cohen‐solal Influential?
(Suggest an Edit or Addition)Alain Cohen‐solal's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). (2005) (1481)
- The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. (2003) (1421)
- Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. (2007) (939)
- State of the art: Using natriuretic peptide levels in clinical practice (2008) (780)
- The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment (2003) (738)
- The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. (2003) (724)
- Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. (2007) (684)
- Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey (2002) (564)
- Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes: Observations From the Global Registry of Acute Coronary Events (GRACE) (2004) (507)
- Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). (2009) (449)
- 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. (2017) (447)
- [Ventricular "remodeling" after myocardial infarction]. (1991) (415)
- Clinical profile, contemporary management and one‐year mortality in patients with severe acute heart failure syndromes: The EFICA study ☆ (2006) (357)
- Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction: Results of the CHARM Low–Left Ventricular Ejection Fraction Trials (2004) (349)
- Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and Rehabilitation (2009) (343)
- Methodological approach to the first and second lactate threshold in incremental cardiopulmonary exercise testing (2008) (329)
- Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study (2003) (299)
- Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (2020) (280)
- Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. (2006) (280)
- Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. (2005) (268)
- Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency (2017) (255)
- Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. (2013) (224)
- Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. (2020) (223)
- Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. (2013) (223)
- A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. (2000) (217)
- Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. (2014) (211)
- A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure. (2002) (209)
- Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388–2442 and Eur J Heart Fail 2008;10:933–989] (2009) (208)
- Secondary prevention through cardiac rehabilitation: position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. (2003) (189)
- Prolonged kinetics of recovery of oxygen consumption after maximal graded exercise in patients with chronic heart failure. Analysis with gas exchange measurements and NMR spectroscopy. (1995) (184)
- Physical activity for primary and secondary prevention. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology (2003) (173)
- The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe (2000) (173)
- Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β‐blockers in SURVIVE † (2009) (172)
- Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio‐Oncology Council of the European Society of Cardiology (ESC) (2020) (165)
- Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. (2012) (163)
- Relation between volume of exercise and clinical outcomes in patients with heart failure. (2012) (160)
- Evidence for altered interleukin (IL)‐18 pathway in human heart failure (2004) (152)
- Practical recommendations for the use of ACE inhibitors, beta‐blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice (2005) (144)
- Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo‐controlled trial (2017) (143)
- Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes. (2001) (141)
- Isolated left ventricular non‐compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry (2011) (137)
- Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. (1999) (133)
- Trends in death attributed to heart failure over the past two decades in Europe (2012) (133)
- Effects of Serelaxin in Patients with Acute Heart Failure. (2019) (129)
- High prevalence of iron deficiency in patients with acute decompensated heart failure (2014) (124)
- Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. (2008) (123)
- Public awareness of heart failure in Europe: first results from SHAPE. (2005) (123)
- Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. (2009) (122)
- CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction. (2021) (122)
- Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge (2018) (118)
- Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology (2020) (118)
- Transient Left Ventricular Basal Dysfunction without Coronary Stenosis in Acute Cerebral Disorders: A Novel Heart Syndrome (Inverted Takotsubo) (2005) (117)
- A critical appraisal of the prognostic value of the VE/VCO2 slope in chronic heart failure (2003) (117)
- Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. (2020) (117)
- Predictors of clinical outcomes in elderly patients with heart failure (2011) (116)
- Precipitating factors and 90‐day outcome of acute heart failure: a report from the intercontinental GREAT registry (2017) (115)
- Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. (1998) (114)
- Iron deficiency: an emerging therapeutic target in heart failure (2014) (113)
- Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. (2013) (113)
- Galectin‐3 in heart failure with preserved ejection fraction (2013) (109)
- French Society of Cardiology guidelines for cardiac rehabilitation in adults. (2012) (107)
- Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part I: Definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure (2006) (105)
- Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa on hemoglobin response and symptoms in patients with heart failure and anemia (2006) (103)
- Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study (2018) (102)
- Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion (2018) (97)
- Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial (2009) (96)
- Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines (2020) (95)
- Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. (2008) (93)
- Heart failure and diabetes mellitus: epidemiology and management of an alarming association. (2008) (91)
- Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part II: How to perform cardiopulmonary exercise testing in chronic heart failure (2006) (91)
- Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy: an in vivo PET study. (1997) (88)
- Executive summary of the Position Paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology (ESC): core components of cardiac rehabilitation in chronic heart failure (2005) (87)
- Benefits of exercise training in chronic heart failure. (2009) (87)
- Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice (2018) (82)
- Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure. (2015) (81)
- Comparison of treadmill and bicycle exercise in patients with chronic heart failure. (1994) (80)
- Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction. Part II: Interpretation of cardiopulmonary exercise testing in chronic heart failure and future applications. (2006) (78)
- Absence of Exercise Capacity Improvement After Exercise Training Program: A Strong Prognostic Factor in Patients With Chronic Heart Failure (2008) (77)
- CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. (2020) (77)
- Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failure. (2012) (76)
- Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity‐score matched study (2018) (76)
- Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. (2006) (76)
- Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle exercise in chronic heart failure. Comparison of graphical methods, interobserver variability and influence of the exercise protocol. The VO2 French Study Group. (1991) (73)
- Diagnosis of aortic valvular stenosis by multislice cardiac computed tomography. (2006) (73)
- Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate‐lowering properties (2014) (71)
- Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS (2012) (70)
- Assessment of longitudinal and radial ventricular dyssynchrony in ischemic and nonischemic chronic systolic heart failure: a two-dimensional echocardiographic speckle-tracking strain study. (2008) (67)
- Interaction between pulse wave velocity, augmentation index, pulse pressure and left ventricular function in chronic heart failure (2006) (65)
- Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design. (2002) (65)
- Neprilysin, cardiovascular, and Alzheimer's diseases: the therapeutic split? (2015) (64)
- The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion. (2016) (62)
- Comparison of the long term prognostic value of peak exercise oxygen pulse and peak oxygen uptake in patients with chronic heart failure (1997) (60)
- So many definitions of heart failure: are they all universally valid? A critical appraisal (2010) (59)
- Left ventricular‐arterial coupling in systemic hypertension: analysis by means of arterial effective and left ventricular elastances (1994) (58)
- Effects of aging on left ventricular-arterial coupling in man: assessment by means of arterial effective and left ventricular elastances. (1996) (54)
- Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction. (2017) (53)
- Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative (1999) (53)
- Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors (2021) (52)
- Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure. (2005) (52)
- Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part III: Interpretation of cardiopulmonary exercise testing in chronic heart failure and future applications: Task Force of the Italian Work (2006) (51)
- Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. (2001) (50)
- Study of muscular and ventricular function in dynamic cardiomyoplasty: a ten-year follow-up. (1997) (49)
- Ventilatory Efficiency and the Selection of Patients for Heart Transplantation (2010) (49)
- The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study (2011) (49)
- Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort (2015) (47)
- Cardiac and peripheral responses to exercise in patients with chronic heart failure. (1999) (47)
- Treatment of Heart Failure With Celiprolol, a Cardioselective Beta Blocker With Beta-2 Agonist Vasodilatory Properties (2000) (45)
- Delayed acute myocarditis and COVID‐19‐related multisystem inflammatory syndrome (2020) (44)
- Cardiac resynchronisation therapy reduces functional mitral regurgitation during dynamic exercise in patients with chronic heart failure: an acute echocardiographic study (2005) (44)
- Ejection fraction and blood pressure are important and interactive predictors of 4‐week mortality in severe acute heart failure (2007) (43)
- Ventilatory threshold during exercise in patients with mild to moderate chronic heart failure: determination, relation with lactate threshold and reproducibility. (1991) (41)
- Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients (2020) (41)
- Pulmonary hypertension following hepatopulmonary syndrome in a patient with cirrhosis. (1999) (41)
- Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure. (2015) (39)
- Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure (2016) (39)
- An education program for risk factor management after an acute coronary syndrome: a randomized clinical trial. (2014) (38)
- Effects of a cardiac rehabilitation programme on plasma cardiac biomarkers in patients with chronic heart failure (2017) (37)
- Prognostic markers of acute decompensated heart failure: the emerging roles of cardiac biomarkers and prognostic scores. (2015) (37)
- Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance (2017) (37)
- Non‐invasive radial pulse wave assessment for the evaluation of left ventricular systolic performance in heart failure (2007) (36)
- Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy. (2006) (36)
- Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme. (2008) (36)
- Comparison using dynamic vectorcardiography and MIBI SPECT of ST-segment changes and myocardial MIBI uptake during percutaneous transluminal coronary angioplasty of the left anterior descending coronary artery. (1995) (35)
- The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials. (2021) (35)
- Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in‐hospital phase and 30‐day follow‐up (2017) (34)
- Soluble CD146 Is a Novel Marker of Systemic Congestion in Heart Failure Patients: An Experimental Mechanistic and Transcardiac Clinical Study. (2017) (34)
- 1145-122 Prevention of atrial fibrillation in symptomatic chronic heart failure by candesartan: Results from CHARM (2004) (34)
- Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe (2004) (34)
- Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial (2022) (34)
- Favourable 5-year postdischarge survival of comatose patients resuscitated from out-of-hospital cardiac arrest, managed with immediate coronary angiogram on admission (2014) (33)
- Comparison of the prognostic value of left ventricular filling and peak oxygen uptake in patients with systolic heart failure. (2000) (33)
- The Arterial System in Hypertension (1993) (33)
- Management of acute heart failure in elderly patients. (2016) (33)
- The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions. (2020) (32)
- β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure (2010) (32)
- Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists. (2014) (31)
- Left ventricular-arterial system coupling at peak exercise in dilated nonischemic cardiomyopathy. (1998) (31)
- Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’ (2019) (30)
- Molecular mechanisms in evolutionary cardiology failure (2010) (30)
- Can anaerobic threshold be used as an end-point for therapeutic trials in heart failure? Lessons from a multicentre randomized placebo-controlled trial. The VO2 French Study Group. (1994) (29)
- Acute Kidney Injury Induces Remote Cardiac Damage and Dysfunction Through the Galectin-3 Pathway (2019) (29)
- Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose‐mediated deleterious effect (2003) (29)
- Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications (2018) (28)
- Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation. (2020) (27)
- Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice (2020) (27)
- The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin (2018) (26)
- Comparison of left ventricular responses to the six-minute walk test, stair climbing, and maximal upright bicycle exercise in patients with congestive heart failure due to idiopathic dilated cardiomyopathy. (1997) (26)
- Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group. (2000) (26)
- Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022) (25)
- 2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy. (2020) (24)
- Loss of Notch3 Signaling in Vascular Smooth Muscle Cells Promotes Severe Heart Failure Upon Hypertension (2016) (24)
- Cardiopulmonary response during exercise of a beta 1-selective beta-blocker (atenolol) and a calcium-channel blocker (diltiazem) in untrained subjects with hypertension. (1993) (24)
- COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology (2021) (24)
- Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe. (2003) (23)
- Cardiac resynchronisation as a rescue therapy in patients with catecholamine‐dependent overt heart failure: Results from a short and mid‐term study (2008) (22)
- Trends in death attributed to myocardial infarction, heart failure and pulmonary embolism in Europe and Canada over the last decade. (2014) (22)
- Corrigendum to ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008’ [Eur Heart J 2008;29:2388–2442 and Eur J Heart Fail 2008;10:933–989] (2008) (22)
- Concordance Between Mechanical and Electrical Dyssynchrony in Heart Failure Patients: A Function of the Underlying Cardiomyopathy? (2007) (22)
- Diastolic heart failure: myth or reality? (2002) (21)
- QSOX1, a novel actor of cardiac protection upon acute stress in mice. (2018) (21)
- Modern‐day cardio‐oncology: a report from the ‘Heart Failure and World Congress on Acute Heart Failure 2018’ (2018) (21)
- Cardiopulmonary Exercise Testing in Chronic Heart Failure (2007) (21)
- Peak oxygen uptake during exercise in mitral stenosis with sinus rhythm or atrial fibrillation: lack of correlation with valve area. A study in 70 patients. (1994) (20)
- Study design of a mortality trial with intravenous levosimendan - the SURVIVE study - in patients with acutely decompensated heart failure (2004) (20)
- Increasing Awareness and Perception of Heart Failure in Europe and Improving Care—Rationale and Design of the SHAPE Study (2004) (20)
- Subclinical Left Ventricular Dysfunction During Chemotherapy (2018) (20)
- RESICARD: East Paris network for the management of heart failure: absence of effect on mortality and rehospitalization in patients with severe heart failure admitted following severe decompensation. (2009) (19)
- Physical activity: from epidemiological evidence to individualized patient management. (2014) (19)
- Update on the medical treatment of stable angina. (2011) (19)
- Diagnostic score of cardiac involvement in AL amyloidosis. (2020) (18)
- Effects of spironolactone on ventricular-arterial coupling in patients with chronic systolic heart failure and mild symptoms (2015) (18)
- Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors (2007) (18)
- Physical activity for patients with heart failure: Position paper from the heart failure (GICC) and cardiac rehabilitation (GERS-P) Working Groups of the French Society of Cardiology. (2019) (18)
- Nonlimited exercise test combined with high-dose dipyridamole for thallium-201 myocardial single-photon emission computed tomography in coronary artery disease. (1995) (18)
- Left ventricular diastolic dysfunction: pathophysiology, diagnosis and treatment. (1998) (17)
- Delayed attainment of peak oxygen consumption after the end of exercise in patients with chronic heart failure. (1997) (17)
- Management of Immune Checkpoint Inhibitor–Induced Myocarditis (2021) (16)
- East Asia may have a better 1‐year survival following an acute heart failure episode compared with Europe: results from an international observational cohort (2018) (16)
- Proteomics analysis reveals IGFBP2 as a candidate diagnostic biomarker for heart failure (2015) (15)
- Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis (2020) (15)
- Budget impact of intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency in France (2019) (15)
- Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era (2020) (15)
- Potential interests of heart rate lowering drugs (1999) (15)
- Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year. (2005) (15)
- Effects of Cardiopulmonary Exercise Rehabilitation on Left Ventricular Mechanical Efficiency and Ventricular‐Arterial Coupling in Patients With Systolic Heart Failure (2015) (14)
- Serial assessment of cardiopulmonary exercise capacity after cardiomyoplasty for either ischemic or idiopathic dilated cardiomyopathy. (1996) (14)
- Value of mechanical dyssynchrony as assessed by radionuclide ventriculography to predict the cardiac resynchronization therapy response. (2016) (13)
- Regional differences in exercise training implementation in heart failure: findings from the Exercise Training in Heart Failure (ExTraHF) survey (2019) (13)
- Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (13)
- Non-vitamin K antagonist oral anticoagulants and heart failure. (2016) (13)
- Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence. (2020) (13)
- Measuring physical activity with activity monitors in patients with heart failure: from literature to practice. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology (2020) (12)
- Use of tamoxifen in a German shepherd dog with sclerosing encapsulating peritonitis. (2010) (12)
- Recurrent valvular replacement due to exacerbation of Behcet's disease by Streptococcus agalactiae infection. (2003) (12)
- Heart failure diagnosis in acute conditions has high agreement with inpatient diagnosis (2016) (11)
- Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology (2022) (11)
- Colour tissue Doppler underestimates myocardial velocity as compared to spectral tissue Doppler: poor reliability between both methods. (2007) (11)
- Improving exercise tolerance in patients with chronic heart failure: should we treat the heart or the periphery? VO2 French Study Group. (1989) (11)
- Peripheral muscle ergoreceptors and ventilatory response during exercise recovery in heart failure. (1999) (11)
- Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (10)
- Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial. (2022) (10)
- [Exercise capacity after heart transplantation]. (1995) (10)
- Hemoglobin and Clinical Outcomes in the VerICiguaT Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA). (2021) (10)
- Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action (2022) (10)
- Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy (2017) (10)
- ST-segment elevation in precordial leads: anterior or right ventricular myocardial infarction? (2001) (10)
- Thromboembolism and bleeding in systemic amyloidosis: a review (2021) (10)
- Mega‐trials in heart failure: effects of dilution in examination of new therapies (2020) (10)
- [Registry of cardiac insufficiency in cardiology]. (2001) (10)
- Effects of altitude on effort tolerance in non-acclimatized patients with ischemic left ventricular dysfunction (2006) (10)
- Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study. (2007) (10)
- A patency-oriented strategy for early management of acute myocardial infarction using emergency coronary angiography and selective coronary angioplasty. (1992) (9)
- Changes in ventricular–arterial coupling during decongestive therapy in acute heart failure (2014) (9)
- Doxorubicin‐induced and trastuzumab‐induced cardiotoxicity in mice is not prevented by metoprolol (2021) (9)
- Natriuretic peptides in addition to Zwolle score to enhance safe and early discharge after acute myocardial infarction: A prospective observational cohort study. (2016) (9)
- RELAX‐AHF, BLAST‐AHF, TRUE‐AHF, and other important truths in acute heart failure research (2017) (9)
- 2020 Recommendations from the French Society of Rheumatology for the management of gout: management of acute flares. (2020) (9)
- Clinical Experience of Dabigatran and Rivaroxaban in Electrical Cardioversion of Atrial Fibrillation (2015) (9)
- Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group (2021) (9)
- Dissociation Between Improvement in Left Ventricular Performance and Functional Class in Patients With Chronic Heart Failure (2005) (9)
- Association between baseline cardiovascular mechanics and exercise capacity in patients with coronary artery disease (2015) (8)
- Baseline subendocardial viability ratio influences left ventricular systolic improvement with cardiac rehabilitation (2016) (8)
- Iron deficiency in heart failure patients: the French CARENFER prospective study (2022) (8)
- The management of patients with heart failure in France (2000) (8)
- Peak exercise responses in heart failure: back to basics. (2009) (8)
- Linee guida ESC per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico 2008 = Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (2009) (7)
- Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health within the general population: Recommendations from the EACPR (Part I) Short title: Exercise and PA characteristics in primary prevention (2012) (7)
- Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study (2020) (7)
- Assessment of dyspnoea in the emergency department by numeric and visual scales: A pilot study. (2015) (7)
- Clinical evaluation of the Heart Check system, a new quantitative measurement of fresh capillary BNP. (2015) (7)
- Steady endothelial nitric oxide synthase expression in heart failure. (2007) (7)
- Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure (2004) (6)
- [Management of heart failure by general practitioners in France. Results of the study IMPROVEMENT of heart failure (IMPROVEMENT-HF)]. (2002) (6)
- The value of novel invasive hemodynamic parameters added to the TIMI risk score for short-term prognosis assessment in patients with ST segment elevation myocardial infarction. (2016) (6)
- Ambulatory cardiac rehabilitation facilities should be present in every cardiology department (2018) (6)
- Left Atrioventricular Coupling Index to Predict Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis (2021) (6)
- HypnosIS to faciLitate trans-Esophageal echocardiograPhy Tolerance: The I-SLEPT study. (2016) (6)
- HIGH PREVALENCE OF IRON DEFICIENCY IN PATIENTS ADMITTED FOR ACUTE DECOMPENSATED HEART FAILURE: A FRENCH STUDY (CARDIOFER) (2014) (5)
- "Diastolic" heart failure, overlooked systolic dysfunction, altered ventriculo-arterial coupling or limitation of cardiac reserve? (2008) (5)
- The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey (2020) (5)
- Transient fall in oxygen intake during exercise in congestive heart failure. (1996) (5)
- Role of aldosterone in heart failure (2000) (5)
- 449 Levosimendan reduces mortality when compared with dobutamine in patients receiving beta blockers (2007) (5)
- Sunday, 26 August 2012 (2012) (5)
- [Hydatid cyst of the right heart and post-embolic pulmonary hypertension]. (1987) (5)
- Determinants and outcomes of congestive heart failure complicating acute coronary syndromes: observations from the global registry of acute coronary events (2002) (5)
- Exercise Training in Chronic Heart Failure: Why? (1999) (5)
- Right ventricular function and iron deficiency in acute heart failure. (2020) (5)
- Protein S100B as a reliable tool for early prognostication after cardiac arrest. (2020) (5)
- Towards a Common Definition for the Diagnosis of Iron Deficiency in Chronic Inflammatory Diseases (2022) (5)
- Increased dose of diuretics correlates with severity of heart failure and renal dysfunction and does not lead to reduction of mortality and rehospitalizations due to acute decompensation of heart failure; data from AHEAD registry (2018) (4)
- Acute heart failure treatment: a light at the end of the tunnel? (2021) (4)
- Association between hemoglobin level and cardiopulmonary performance in heart failure: insights from the HF-ACTION study. (2013) (4)
- Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF (2022) (4)
- Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: an international cardiology survey (2022) (4)
- Very early management of acute heart failure syndromes. (2011) (4)
- Iron deficiency in pulmonary arterial hypertension: perspectives (2021) (4)
- Pathophysiology of Acute Heart Failure (1988) (4)
- Acute Hemodynamic Effects of SIN-1 vs. Isosorbide Dinitrate: A Double-Blind, Crossover Study in Stable Chronic Left Ventricular Failure (1991) (4)
- Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patients. (2017) (4)
- Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial (2022) (3)
- Effects of exercise on postexercise ventricular–arterial coupling and pulsatile efficiency in patients with systolic dysfunction (2015) (3)
- [Exercise training in cardiac patients: usefulness of the cardiopulmonary exercise test]. (2006) (3)
- Cardiopulmonary Response During Exercise of a β1-Selective β‐Blocker (Atenolol) and a Calcium‐Channel Blocker (Diltiazem) in Untrained Subjects with Hypertension (1993) (3)
- Peripheral muscle ergoreceptors and ventilatory response during exercise recovery in heart failure. (1999) (3)
- Unusual pseudotumoral right atrial involvement in Listeria monocytogenes septicemia. (2012) (3)
- Is the glass half full or half empty after PARAGON-HF? (2020) (3)
- Beneficial effects of exercise training in heart failure are lost in male diabetic rats. (2017) (3)
- [Brain natriuretic peptide (BNP) in coronary insufficiency: relationship with left ventricular filling and exercise tolerance]. (1999) (3)
- Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How? (2022) (3)
- [Economic study of carvedilol in heart failure. A cost effectiveness study in France]. (2001) (3)
- [Thrombolysis in acute myocardial infarction. Re-evaluation]. (1986) (2)
- [Reduction of auricular fibrillation and tachycardia using intravenous flecainide]. (1987) (2)
- Education and certification on heart failure of the Heart Failure Association of the European Society of Cardiology (2022) (2)
- Effects of Physical Exercise on Cardiovascular Diseases: Biochemical, Cellular, and Organ Effects (2015) (2)
- [Measurement of oxygen consumption during exertion in patients with cardiac failure]. (1988) (2)
- Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study (2022) (2)
- Limitations of radionuclide angiographic assessment of left ventricular systolic function before lung transplantation. (1998) (2)
- Determinants of left atrioventricular coupling index: The Multi-Ethnic Study of Atherosclerosis (MESA). (2022) (2)
- Effect of atrial fibrillation on exercise capacity in mitral stenosis. (1996) (2)
- proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action (2022) (2)
- [Heart failure and cachexia]. (2006) (2)
- Physiology of the abnormal response of heart failure patients to exercise (2004) (2)
- [Properties of arteries, cardiac function and structure in chronic hypertension]. (1991) (2)
- [Abnormalities of the peripheral circulation and tolerance to exertion of patients with heart failure]. (1989) (2)
- Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation (2023) (2)
- Iron deficiency in heart failure: why so frequent and which mechanisms? (2019) (2)
- Characterization of non‐response to cardiac resynchronization therapy by post‐procedural computed tomography (2020) (2)
- Determination of left ventricular cardiac volume by simultaneous radionuclide angiography and measurement of oxygen consumption at rest and during maximal exercise: a comparison of two non-invasive isotopic procedures. (1996) (2)
- Sex, Jogging, and Mortality: The Copenhagen City Heart Study. (2015) (2)
- [Critical analysis of scales of quality of life in cardiology; applications to cardiac insufficiency]. (1994) (2)
- [Prognostic significance of early raised cardiac troponine I in unstable angina. Contribution to the identification of a high-risk sub-group]. (1997) (2)
- [Functional coupling of the left ventriculo-arterial system and aging in man]. (1992) (1)
- Prognostic Value of Iodine-123-Metaiodobenzylguanidine Scintigraphy in Light-Chain Amyloidosis. (2019) (1)
- Hemoglobin, anemia, and clinical outcomes in vericiguat global study in subjects with heart failure with reduced ejection fraction (VICTORIA) (2021) (1)
- Value of Baseline Cardiovascular Mechanics in Predicting Exercise Training Success (2016) (1)
- [Is ejection fraction an index of left ventricular function and/or of the condition of the arterial system?]. (1993) (1)
- [Functional mitral insufficiency: a neglected vascular lesion?]. (2001) (1)
- [Ambulatory management of chronic cardiac failure. Possible value of health networking]. (2000) (1)
- Levosimendan Reduces Mortality When Compared with Dobutamine in Patients Receiving Beta Blockers: The SURVIVE Study (2007) (1)
- Towards Holistic Heart Failure Management—How to Tackle the Iron Deficiency Epidemic? (2017) (1)
- 097 Patterns of acute heart failure in nonagenarians (2011) (1)
- 0163: Renal arterial resistance index versus biomarkers for predicting acute kidney injury in acute heart failure (2015) (1)
- 494 Levosimendan, compared to dobutamine, reduces mortality in patients with a history of heart failure (2007) (1)
- Evaluation of Maintained PhysicAl CaPacity 1-yr After Coronary Patient Cardiac Rehabilitation (EMAP) (2022) (1)
- [Massive pulmonary embolism and stroke due to thrombus across the foramen ovale]. (2006) (1)
- P70Circulating microRNAs and outcome in patients with acute heart failure (2014) (1)
- Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials. (2021) (1)
- [Acute myocardial infarction. Experiences of the referral network of the Beaujon and Bichat hospitals (with the collaboration of the Emergency Medical and Resuscitation Service of Beaujon)]. (1998) (1)
- [Angiotensin II antagonists: a promising pathway]. (2000) (1)
- Budget Impact of IV Iron Therapy with Ferric Carboxymaltose In Patients with Chronic Heart Failure And Iron Deficiency In France (2017) (1)
- NT-proBNP and High-Sensitivity Troponin T Hold Diagnostic Value in Cardiac Amyloidosis. (2022) (1)
- [Neuroendocrine changes in chronic cardiac insufficiency]. (1988) (1)
- Targeting the ‘vulnerable’ period – first 3–6 months after an acute heart failure admission – the light gets brighter (2022) (1)
- Levosimendan, Compared to Dobutamine, Reduces Mortality in Patients with a History of Heart Failure: SURVIVE (2007) (1)
- Coronary Computed Tomography Angiography Analysis of Calcium Content to Identify Non-culprit Vulnerable Plaques in Patients With Acute Coronary Syndrome (2022) (1)
- Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment. (2023) (1)
- Variations in therapy for heart failure in Europe: from perceptions to practice. A study of over 1300 physicians and > 11,000 patients (2001) (1)
- [Diabetes and heart failure, a fatal association]. (2007) (1)
- High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis (2020) (1)
- Severe Myocardial Dysfunction after Non-Ischemic Cardiac Arrest: Effectiveness of Percutaneous Assist Devices (2021) (1)
- Hospital management of heart failure: improvement but still room for improvement at discharge... (2008) (1)
- PHARMACOLOGICAL INHIBITION OF GALECTIN-3 AND ALDOSTERONE PATHWAYS PREVENTS ISOPROTERENOL-INDUCED LEFT VENTRICULAR DYSFUNCTION AND FIBROSIS IN MICE (2015) (1)
- European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment (2022) (1)
- Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research (2021) (1)
- [Prevention of heart failure]. (1998) (1)
- [Hemodynamic evaluation of the Carpentier-Edwards porcine bioprosthesis and the Hancock pericardial bioprosthesis in aortic position]. (1986) (1)
- [Effects of aging on left ventricle-arterial coupling in man]. (1993) (0)
- [Precautions for use and contraindications of thiazolidinediones. A cardiologist opinion]. (2002) (0)
- P3436The J-curve relationship between admission glucose level and 1-year mortality in patients with acute heart failure: results from an international observational cohort (2018) (0)
- Non invasive LV function assessment by simultaneous radionuclide angiography and oxygen consumption at rest and during exercise (1995) (0)
- [Left heart failure and coronary artery disease in COPD]. (2003) (0)
- [Heart insufficiency in the elderly]. (2001) (0)
- 7 – Les valvulopathies (2009) (0)
- 010 Anemia for Risk Assessment of Patients With Acute Coronary Syndromes (2010) (0)
- 458 Poor treatment of patients with heart failure: lack of knowledge of current guidelines by cardiologists or too few patients treated by cardiologists? Results of SHAPE (2005) (0)
- Spreading of the new treatments in heart failure. Presentation of an initiative: Improvement of heart failure (2000) (0)
- [Diagnosis of diastolic heart failure]. (2002) (0)
- Oxygen uptake should be measured and not estimated in patients with heart failure (2002) (0)
- [Exercise test in the evaluation of cardiac failure]. (1997) (0)
- 407 Candesartan is cost‐effective in heart failure ‐ an economic analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme (2005) (0)
- Technical aspects of radionuclide imaging oral abstract session (2005) (0)
- Prognostic value of soluble ST2 in chronic heart failure (2022) (0)
- [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results]. (1989) (0)
- [Value of early vasodilator treatment with prazosin in chronic cardiac insufficiency]. (1987) (0)
- 0195: Early predictive factors of LV remodeling after STEMI; assessment by coronary angiogram and cadiovascular magnetic resonance (2014) (0)
- Management of Heart Failure Patients with Preserved Left Ventricular Ejection Fraction (2005) (0)
- [Methods of evaluation of left ventricular dysfunction]. (1993) (0)
- Are beta blockers effective in elderly patients wiih heart failure and preserved ejection fraction? Results from the randomised, multinational seniors trial (2006) (0)
- CARDIOVASCULAR BACKGROUND AND SPORT ACTIVITY OF LICENCED FRENCH SOCCER AMATEUR PLAYERS: THE CARDIO-GOAL SURVEY. (2011) (0)
- [What is the appropriate treatment for myocardial infarction with left ventricular dysfunction?]. (1994) (0)
- [Use of carvedilol in daily practice]. (1999) (0)
- [Evaluation of bidimensional echography in the etiological orientation of pericardial disease. Apropos of 39 anatomo-echographic comparisons]. (1987) (0)
- [Cortico-sensitive asphyxiating pneumopathy in acute disseminated lupus erythematosus in a patient with silicosis]. (1981) (0)
- [Role of digitalis glycosides in the treatment of cardiac failure]. (1994) (0)
- [Severe sinusal dysfunction following treatment with lithium in therapeutic doses]. (1987) (0)
- miRNAs: new biomarkers of cardiac rehabilitation response? (2021) (0)
- Transient Fall inOxygen Intake During Exercise inCongestive (2015) (0)
- 42 Prevalence and determinants of atrial dyssynchrony in heart failure patients (2015) (0)
- A national survey of heart failure in French hospitals for the Myocardiopathy Heart Failure of the (2000) (0)
- Influence of age and ejection fraction on the effects of nebivolol in elderly patients with heart failure (2005) (0)
- [Methodologic and clinical lessons of large-scale trials of thrombolytic agents]. (1989) (0)
- All rise! Orthostatic hypotension in heart failure: reply (2020) (0)
- 360 Hypnosis: a new method to facilitate trans-oesophageal echocardiography. The I-SLEPT study (2012) (0)
- [Management of severe acute pulmonary edema]. (2000) (0)
- [Multiparameter correlative study of respiratory gas exchange during exercise]. (1988) (0)
- Hungarian results of the IMPROVEMENT HF European survey on the everyday diagnostics and treatment of heart failure: Comparison of European and Hungarian data (2003) (0)
- 135 Hypnosis: a new alternative to facilitate trans-esophageal echocardiography (2011) (0)
- [Treating heart failure with carvedilol in private practice (initiating treatment and follow-up at one year. The KEOPS study]. (2007) (0)
- in Seniors With Heart Failure) (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization and Preserved Left Ventricular Ejection Fraction: Data From SENIORS Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired (2011) (0)
- Arterial system, left ventricular structure and function (1993) (0)
- Betablockers and calcium antagonists do not reduce exercise performance in hypertension: Assessment by respiratory gas analysis (1991) (0)
- Acute heart failure (AHF) 307 P1491 | BEDSIDE Gender related differences in long-term outcomes of acute heart failure patients from different geographic regions (0)
- Early changes in ventricular-arterial coupling in acutely decompensated systolic heart failure (ADSHF): An echocardiography and arterial tonometry study (2013) (0)
- [Secondary prevention after myocardial infarction; role of beta blockaders]. (1996) (0)
- [Mechanisms of cardiac failure]. (1997) (0)
- [How to evaluate the hemodynamic risk after myocardial infarction?]. (1992) (0)
- Geographic variation in heart failure with reduced ejection fraction: insights from the VICTORIA trial (2022) (0)
- [Coronary angiography and coronary bypass in patients over 70 (valvular disease excluded). Indications and results]. (1985) (0)
- Heart failure / cardiomyopathy Liver function abnormalities , clinical profile , and outcome in acute decompensated heart failure (2013) (0)
- Risk in special population oral abstract session (2005) (0)
- [Acute hemodynamic effects of SIN-1 and isosorbide dinitrate in stable left ventricular failure: a comparative double-blind, cross-over study]. (1992) (0)
- [Functional capacity after cardiac transplantation]. (1994) (0)
- Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 ESC heart failure guidelines into clinical practice: (2018) (0)
- Iconography : Benefits of exercise training in chronic heart failure (2009) (0)
- Hemodynamic Interaction of Aspirin With Enalapril (1999) (0)
- Discovery and validation of a new biomarker for heart failure diagnostic (2018) (0)
- [Diuretics. Principles and rules for their use]. (1991) (0)
- [Converting enzyme inhibitors and cardiac insufficiency: current findings and perspectives]. (1990) (0)
- [Left ventricular hypertrophy and arterial hypertension. Should it be taken into account?]. (1992) (0)
- [Mediastinal involvement in primary amyloidosis with monoclonal gammopathy. Two case-reports (author's transl)]. (1982) (0)
- Nonlimited Exercise Test Combined With Hi 8 h-Dose Pi Thallium-2 1 % yridamole for Myocar lal Single-Photon Emission Computed Tomography in Coronary Artery Disease (1995) (0)
- [Disorders of diastolic function in chronic left ventricular insufficiency]. (1990) (0)
- Cardiovascular Prevention and Rehabilitation patients: a report from the Exercise Physiology Section of the European Association for Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac (2012) (0)
- Editorial Manager(tm) for European Journal of Cardiovascular Prevention and Rehabilitation Manuscript Draft Manuscript Number: Title: STANDARDS FOR THE USE OF CARDIOPULMONARY EXERCISE TESTING FOR FUNCTIONAL EVALUATION OF CARDIAC PATIENTS A Report from the Exercise Physiology Section of the European (2008) (0)
- Levosimendan Compared to Dobutamine Does Not Adversely Impact Mortality in Patients with Transient Worsening Renal Function: SURVIVE (2007) (0)
- 007 Predictors of Infarct Size and Microvascular Obstruction Assessed by Cardiac Magnetic Resonance Imaging in patients with Acute ST elevation MI (2010) (0)
- [Indications for heart transplantation (excluding emergencies)]. (1996) (0)
- 126 Insight into the roles of qSox1 during the acute injury (2012) (0)
- Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association ( HFA ) of the ESC (2023) (0)
- [Left ventricular hypertrophy. Advantages and drawbacks]. (1986) (0)
- 101Characterization of the calcium component of vulnerable coronary plaque in patients with NSTEMI: prospective comparison between coronary CT and optical coherence tomography (2019) (0)
- Abstract 15674: Notch3/rbpjk Signaling Pathway in the Coronary Arteries is Involved in the Development of Heart Failure in Response to Hypertension (2014) (0)
- Rare visualization of entrapped left ventricular thrombi in noncompacted myocardium. (2011) (0)
- New treatments for heart failure and exercise capacity (2021) (0)
- 090 Prognostication in patients with heart failure and intermediate peak oxygen consumption values can be more accurately assessed by heart rate recovery (2011) (0)
- P1491Gender related differences in long-term outcomes of acute heart failure patients from different geographic regions (2017) (0)
- [Sudden death in heart failure. Analysis and prevention]. (1992) (0)
- EE326 Alleviating the Burden of Iron Deficiency in Heart Failure: A Multinational European Study (2022) (0)
- Steady endothelial nitric oxide synthase expression in heart failure (2007) (0)
- 089 Heart rate recovery is a powerful prognostic factor in patients with chronic heart failure (2011) (0)
- [Prevention of postinfarction cardiac insufficiency: role of angiotensin converting enzyme inhibitors]. (1992) (0)
- P6354Decreased beneficial effects of oral heart failure medications in patients with acute decompensated heart failure and hyperglycemia: results from an international observational cohort (2019) (0)
- Two common echocardiographic variables to diagnose cardiac amyloidosis: the AMYLoidosis Index (AMYLI) score (2020) (0)
- [Influence of medical treatments on the functional status in patients with chronic cardiac insufficiency]. (1990) (0)
- Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial? (2022) (0)
- [Determination of the ventilatory threshold during the exercise test in patients with cardiac insufficiency. Relation of the lactate threshold]. (1990) (0)
- La thrombolyse dans l'infarctus myocardique aigu: mise au point (1986) (0)
- [Cardiac insufficiency in the aged]. (1998) (0)
- [Left ventricular remodeling and ischemic heart diseases. Therapeutic possibilities]. (1991) (0)
- [Abnormal peripheral circulation in heart failure]. (1994) (0)
- Schémas d'orientation diagnostique (2009) (0)
- [Negativity of the exercise thallium test despite tight stenosis of the common trunk of the left coronary artery]. (1992) (0)
- exercise testing Methodological approach to the first and second lactate threshold in incremental cardiopulmonary (2008) (0)
- Novel Therapeutic Concepts Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction : integrating evidence into clinical practice (2012) (0)
- Effects of Sacubitril/Valsartan on cardiovascular biomarkers in chronic heart failure patients (2018) (0)
- Ventricular remodelling: effects of the therapeutics (2006) (0)
- The importance of breathing not properly: Chronic obstructive pulmonary disease as a risk factor for rehospitalization in heart failure. (2019) (0)
- 972 Assessment of cardiac resynchronisation therapy by exercise Doppler-echocardiography in heart failure (2005) (0)
- Exercise rehabilitation in heart failure (2018) (0)
- ASSESSMENT OF DOPPLER ECHOCARDIOGRAPHY FOR THE DIAGNOSIS OF PORTOPULMONARY HYERTENSION (PPHT): A PROSPECTIVE STUDY IN 102 CIRRHOTIC PATIENTS AWAITING FOR LIVER TRANSPLANTATION (LT).: Abstract# 782 Poster Board #‐Session: P39‐III (2000) (0)
- EE60 An Economic Evaluation of Introducing Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients With Heart Failure From the Perspective of Healthcare Payers in Sweden, Germany, France, Poland and Spain (2022) (0)
This paper list is powered by the following services:
